118 related articles for article (PubMed ID: 16981274)
21. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori is not a co-carcinogen in N-methyl-N'-nitro-N-nitrosoguanidine-induced rat gastric carcinogenesis.
Kawaura A; Yamamoto I; Tanida N; Inouye H; Takahashi A; Tonokatsu Y; Sawada Y; Sawada K; Shimoyama T
Tokushima J Exp Med; 1991 Dec; 38(3-4):71-5. PubMed ID: 1843054
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
25. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
26. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
27. Expression of mutant type-p53 products in H pylori-associated chronic gastritis.
Kodama M; Murakami K; Okimoto T; Sato R; Watanabe K; Fujioka T
World J Gastroenterol; 2007 Mar; 13(10):1541-6. PubMed ID: 17461446
[TBL] [Abstract][Full Text] [Related]
28. Intestinal metaplasia of the gastric cardia: a study from Turkey.
Dinçer D; Besisik F; Sahin E; Demir K; Tuncer I; Cevikbas U; Mungan Z; Kaymakoglu S; Boztas G; Ozdil S; Cakaloglu Y; Okten A
Hepatogastroenterology; 2002; 49(46):1153-6. PubMed ID: 12143225
[TBL] [Abstract][Full Text] [Related]
29. Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis.
Sun WH; Yu Q; Shen H; Ou XL; Cao DZ; Yu T; Qian C; Zhu F; Sun YL; Fu XL; Su H
World J Gastroenterol; 2004 Oct; 10(19):2809-13. PubMed ID: 15334675
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection and precancerous lesions of the stomach.
Haziri A; Juniku-Shkololli A; Gashi Z; Berisha D; Haziri A
Med Arh; 2010; 64(4):248-9. PubMed ID: 21246927
[TBL] [Abstract][Full Text] [Related]
31. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.
Dong CX; Deng DJ; Pan KF; Zhang L; Zhang Y; Zhou J; You WC
Int J Cancer; 2009 Jan; 124(2):434-9. PubMed ID: 18821580
[TBL] [Abstract][Full Text] [Related]
33. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases.
Guo DL; Dong M; Wang L; Sun LP; Yuan Y
World J Gastroenterol; 2002 Dec; 8(6):1009-13. PubMed ID: 12439915
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract][Full Text] [Related]
35. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
36. A Review of Therapeutic Effects and the Pharmacological Molecular Mechanisms of Chinese Medicine Weifuchun in Treating Precancerous Gastric Conditions.
Gu Z; Ling J; Cong J; Li D
Integr Cancer Ther; 2020; 19():1534735420953215. PubMed ID: 32865036
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of precancerous lesions of the stomach in Venezuela.
Muñoz N; Kato I; Peraza S; Lopez G; Carrillo E; Ramirez H; Vivas J; Castro D; Sanchez V; Andrade O; Buiatti E; Oliver W
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):41-6. PubMed ID: 8770465
[TBL] [Abstract][Full Text] [Related]
38. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
[TBL] [Abstract][Full Text] [Related]
39. Does tonsillectomy affect the outcome of drug treatment for the eradication of gastric H pylori infection? A pilot study.
Sezen OS; Kubilay U; Erzin Y; Tuncer M; Unver S
Ear Nose Throat J; 2013 Mar; 92(3):127-32. PubMed ID: 23532649
[TBL] [Abstract][Full Text] [Related]
40. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer.
Kim CG; Choi IJ; Lee JY; Cho SJ; Nam BH; Kook MC; Hong EK; Kim YW
J Gastroenterol Hepatol; 2009 Mar; 24(3):469-74. PubMed ID: 19067779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
